new glp-1 agonists England Journalist of Medicine published great article. Read it to learn more about the science behind medications. GLP-1 receptor are increasingly used to treat type 2 diabetes and obesity Machine learning designs new GCGR/GLP-1R

While most people taking GLP-1s deal with daily discomfort rather than emergencies, Carroll says that there are some serious complications worth knowing about, including acute pancreatitis, gallbladder disease, and severe dehydration from prolonged vomiting or diarrhea

Specific drug costs in the GLP-1 class can be quite shocking

Krisanapan P, Suppadungsuk S, Sanpawithayakul K, Thongprayoon C, Pattharanitima P, Tangpanithandee S, Mao MA, Miao J, Cheungpasitporn W

Clinical trials demonstrated 13.7 percent average body weight loss at 72 weeks, with many participants exceeding 15 percent

Food and Drug Administration (FDA) recently approved a once-daily oral version of the Wegovy semaglutide, making it the first GLP-1 receptor agonist pill specifically approved for chronic weight management in adults with obesity, or adults who are overweight with at least one weight-related condition

Chen K, Chen L, Shan Z, Wang G, Qu S, Qin G, et al